Orion Biotechnology Presenting at the 3rd GPCR-Targeted Drug Discovery Summit in Boston
06 mars 2024 20h30 HE
|
Orion Biotechnology Canada Ltd.
Ottawa, Canada, March 06, 2024 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously undruggable G...
Orion Biotechnology Completes Discovery of First-in-Class Molecule Against Undrugged GPCR Target in Four Months
18 juil. 2023 11h33 HE
|
Orion Biotechnology Canada Ltd.
Ottawa, Canada, July 18, 2023 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously undruggable G...
Orion Biotechnology Presenting at the 2nd GPCR-Targeted Drug Discovery Summit in Boston
16 févr. 2023 13h15 HE
|
Orion Biotechnology Canada Ltd.
Ottawa, Canada, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously undruggable G...
Orion Biotechnology Publishes Whitepaper Highlighting the Importance and Challenges in Unlocking “Undruggable” GPCRs
02 févr. 2023 10h07 HE
|
Orion Biotechnology Canada Ltd.
Ottawa, Canada, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously undruggable G...
Orion Biotechnology Shares In Vivo Efficacy Data on its Latest Best-in-Class Drug Candidate
01 déc. 2022 11h08 HE
|
Orion Biotechnology Canada Ltd.
Ottawa, Canada, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously undruggable G...
Orion Biotechnology to Attend the LSX Investival Showcase and Jefferies Healthcare Conference
10 nov. 2022 09h03 HE
|
Orion Biotechnology Canada Ltd.
Ottawa, Ontario, Canada, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously...
Orion Biotechnology to present at 2022 Dr. GPCR Summit Conference
11 oct. 2022 09h03 HE
|
Orion Biotechnology Canada Ltd.
Ottawa, Canada, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a drug discovery and development company unlocking the therapeutic potential of previously undruggable G...
Orion Biotechnology and Peptilogics Enter Strategic Research Collaboration to Enable AI-Driven Drug Discovery Against Undrugged GPCR Target
12 juil. 2022 11h22 HE
|
Orion Biotechnology Canada Ltd.
Ottawa, Canada & Pittsburgh, USA, July 12, 2022 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd, a drug discovery company targeting previously undruggable G Protein-Coupled Receptors (GPCRs),...
ORION BIOTECHNOLOGY ADDS GPCR EXPERT TO ITS SCIENTIFIC ADVISORY BOARD
05 juil. 2022 10h03 HE
|
Orion Biotechnology Canada Ltd.
Ottawa, Canada, July 05, 2022 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd, a drug discovery and development company targeting previously-undruggable G Protein-Coupled Receptors (GPCRs), today...
ORION BIOTECHNOLOGY PRESENTING NEW DATA ON ITS LATEST BEST-IN-CLASS GPCR DRUG CANDIDATE
10 mai 2022 13h03 HE
|
Orion Biotechnology Canada Ltd.
Ottawa, Canada, May 10, 2022 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd, a drug discovery and development company unlocking the therapeutic potential of G Protein-Coupled Receptors (GPCRs),...